These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1244 related articles for article (PubMed ID: 22232370)

  • 1. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.
    Brooke JS
    Clin Microbiol Rev; 2012 Jan; 25(1):2-41. PubMed ID: 22232370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen.
    Brooke JS
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):1-4. PubMed ID: 24308713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility pattern of Burkholderia cepacia complex & Stenotrophomonas maltophilia over six years (2007-2012).
    Gautam V; Kumar S; Kaur P; Deepak T; Singhal L; Tewari R; Ray P
    Indian J Med Res; 2015 Oct; 142(4):492-4. PubMed ID: 26609043
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z; Qin J; Liu Y; Li C; Ying C
    BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Baumrin E; Piette EW; Micheletti RG
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29269358
    [No Abstract]   [Full Text] [Related]  

  • 6. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.
    Abbott IJ; Slavin MA; Turnidge JD; Thursky KA; Worth LJ
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):471-88. PubMed ID: 21504403
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Singhal L; Kaur P; Gautam V
    Indian J Med Microbiol; 2017; 35(4):469-479. PubMed ID: 29405136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
    Sannathimmappa MB; Nambiar V; Aravindakshan R; Al-Kasaby NM
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e66-e71. PubMed ID: 33777425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenotrophomonas maltophilia.
    An SQ; Berg G
    Trends Microbiol; 2018 Jul; 26(7):637-638. PubMed ID: 29754971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Toxin-Antitoxin Systems of the Opportunistic Pathogen
    Klimkaitė L; Armalytė J; Skerniškytė J; Sužiedėlienė E
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019620
    [No Abstract]   [Full Text] [Related]  

  • 11. Review on
    Majumdar R; Karthikeyan H; Senthilnathan V; Sugumar S
    Recent Pat Biotechnol; 2022; 16(4):329-354. PubMed ID: 35549857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract.
    Kanderi T; Shrimanker I; Mansoora Q; Shah K; Yumen A; Komanduri S
    Am J Case Rep; 2020 May; 21():e921466. PubMed ID: 32448864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
    Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
    Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia.
    Gröschel MI; Meehan CJ; Barilar I; Diricks M; Gonzaga A; Steglich M; Conchillo-Solé O; Scherer IC; Mamat U; Luz CF; De Bruyne K; Utpatel C; Yero D; Gibert I; Daura X; Kampmeier S; Rahman NA; Kresken M; van der Werf TS; Alio I; Streit WR; Zhou K; Schwartz T; Rossen JWA; Farhat MR; Schaible UE; Nübel U; Rupp J; Steinmann J; Niemann S; Kohl TA
    Nat Commun; 2020 Apr; 11(1):2044. PubMed ID: 32341346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stenotrophomonas maltophilia: an emerging opportunist human pathogen.
    Looney WJ; Narita M; Mühlemann K
    Lancet Infect Dis; 2009 May; 9(5):312-23. PubMed ID: 19393961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
    Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
    Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa Promotes Persistence of Stenotrophomonas maltophilia via Increased Adherence to Depolarized Respiratory Epithelium.
    McDaniel MS; Lindgren NR; Billiot CE; Valladares KN; Sumpter NA; Swords WE
    Microbiol Spectr; 2023 Feb; 11(1):e0384622. PubMed ID: 36472421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
    Mori M; Tsunemine H; Imada K; Ito K; Kodaka T; Takahashi T
    Ann Hematol; 2014 Jun; 93(6):901-11. PubMed ID: 24535696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen
    Fraser TA; Bell MG; Harris PNA; Bell SC; Bergh H; Nguyen TK; Kidd TJ; Nimmo GR; Sarovich DS; Price EP
    Microb Genom; 2019 Oct; 5(10):. PubMed ID: 31617838
    [No Abstract]   [Full Text] [Related]  

  • 20. Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.
    McDaniel MS; Schoeb T; Swords WE
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 63.